The MIT COVID19 Challenge was a 48-hour virtual ‘hackathon’ aimed at identifying and bringing to market innovative solutions to critical problems caused by the pandemic. 1500 participants in 230+ teams came together from 90 countries to tackle various challenges. Divij’s group, Team Nafasi, proposed an innovative technological solution to reduce disease spread at hospitals and to ensure that non-COVID-19 patients have a safe and familiar way to access healthcare.
Related Posts
Anand T and team win MIT’s COVID19 Challenge
We congratulate Dr Anand T, member of the Stem Cell Research Group... read more
Epigenetics and Health
By Dr Rakesh Mishra, Director, TIGS Organisms inherit their genetic make-up as a... read more
Champions of TIGS
The novel Coronavirus (COVID-19) has affected almost every country in the world... read more
The way to a vaccine
By Ashwathi V, Anirudha LakshminarasimhanSince December 2019, scientists all over the world... read more
A Unique Facility for Mosquito Research in the Country
Ever since the Tata Institute for Genetics and Society (TIGS) began in... read more
Sonia Sen talks about how her exposure to nature led her to study the brains of flies and mosquitoes
Sonia’s group at TIGS studies the development and the evolution of the... read more
Reweaving the Tapestry of Life: Biodiversity in a Fast-Changing Planet
By Dr. Meghna Krishnadas, Ecologist Senior Scientist, Council of Scientific and Industrial Research–Centre... read more
Antibody dependent enhancement: A challenge for vaccine development
By Shweta Yadav Vertebrates, including humans, have a complex immune system, which constantly... read more
Biofilms: Beauties to See, Beasts to Treat
By Dr. Karishma S. Kaushik, MBBS, MD, PhD Savitribai Phule Pune University, Pune,... read more